Video: DECLARE-TIMI 58 HFrEF | ACC.19

Dr. Peter Block interviews presenter Dr. Eri Toda Kato regarding dapagliflozin on HF and mortality in diabetes based on EF (DECLARE TIMI-58).


Clinical Topics: Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure

Keywords: ACC Annual Scientific Session, ACC19, Diabetes Mellitus, Type 2, Stroke Volume, Heart Failure, Benzhydryl Compounds, Primary Prevention, Metabolic Syndrome X


< Back to Listings